SK bioscience
SK bioscience and GSK: adjuvanted COVID-19 vaccine SKYCovione.
Other Vaccines GSK:
Medicago’s plant-derived vaccine candidate against COVID-19 uses Coronavirus-Like-Particle (CoVLP) technology with the vaccine composed of recombinant spike (S) glycoprotein expressed as virus-like-particles (VLPs) co-administered with GSK’s pandemic adjuvant.
GSK forscht daneben zusammen mit Curevac an einem weiteren Impfstoffkandidaten; mehr dazu unter "Impfungen" ->"Curevac".